Stipend and Dates
Up to $12,960. Up to 2 screening Visits
|Note: All dates and times are tentative and may change.||Stage 1 Group 3|
|Day -1 Admit - 6:00am||Sep 22, 2022 Thurs|
|*Day 10 - a payment within 10 business days after completion|
|Day 20 Discharge - a payment within 10 business days after completion||Oct 12, 2022 Wed|
|Day 27 Outpatient Visit - a payment within 10 business days completion||Oct 19, 2022 Wed|
Or call 210-225-5437 for more information
Healthy Males – Non-Smoking
BMI: >/18- to 30 kg/m2 Weight: at least 110 pounds
GFR: greater than 90 mL/min
Indication: The investigational drug is being developed as a possible treatment of Parkinson’s disease.
Route of Administration: Oral
Washout from previous study: Receipt of an investigational drug within 30 days before dosing.
Males who are sexually active and whose partners are females of childbearing potential must refrain from donating sperm for at least 90 Days, agree to remain abstinent or must use condoms for the duration of the study and for 90 days following last study dose and their partners must be willing to use a highly effective method of contraception.
- 4 hours fasting is required for lab work (only water is allowed)
- If taking medications, bring them to your screening appointment (including prescription, over the counter, herbal supplements and vitamins)
- Bring a valid, non-expired photo ID with you when you attend your screening visit. We accept a valid government issued identification card such as a driver's license, state issued ID card or passport. You will be required to show this same photo ID at all study visits
- Arrive 30 minutes before your appointment to complete paper work.
- IP 0299-0098 Stage 1
- Healthy Males
- Not Currently Screening.
- Payment amount
- Up to $12,960
- 25 - 55